Mesoblast Stock Technical Analysis

MESO Stock  USD 16.08  0.91  5.36%   
As of the 6th of February, Mesoblast secures the Risk Adjusted Performance of 0.0084, mean deviation of 2.65, and Downside Deviation of 3.32. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mesoblast, as well as the relationship between them.

Mesoblast Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Mesoblast, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to MesoblastMesoblast's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Mesoblast Analyst Consensus

Target PriceConsensus# of Analysts
35.0Strong Buy3Odds
Mesoblast current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Mesoblast analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Mesoblast stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Mesoblast, talking to its executives and customers, or listening to Mesoblast conference calls.
Mesoblast Analyst Advice Details
Will Biotechnology sector continue expanding? Could Mesoblast diversify its offerings? Factors like these will boost the valuation of Mesoblast. Expected growth trajectory for Mesoblast significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Mesoblast data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.85)
Revenue Per Share
0.14
Quarterly Revenue Growth
4.586
Return On Assets
(0.05)
Return On Equity
(0.19)
Investors evaluate Mesoblast using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Mesoblast's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Mesoblast's market price to deviate significantly from intrinsic value.
Understanding that Mesoblast's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Mesoblast represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Mesoblast's market price signifies the transaction level at which participants voluntarily complete trades.

Mesoblast 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mesoblast's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mesoblast.
0.00
11/08/2025
No Change 0.00  0.0 
In 2 months and 31 days
02/06/2026
0.00
If you would invest  0.00  in Mesoblast on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding Mesoblast or generate 0.0% return on investment in Mesoblast over 90 days. Mesoblast is related to or competes with Ocular Therapeutix, Edgewise Therapeutics, Galapagos, Structure Therapeutics, Uniqure NV, Viridian Therapeutics, and Liquidia Technologies. Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapor... More

Mesoblast Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mesoblast's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mesoblast upside and downside potential and time the market with a certain degree of confidence.

Mesoblast Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Mesoblast's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mesoblast's standard deviation. In reality, there are many statistical measures that can use Mesoblast historical prices to predict the future Mesoblast's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Mesoblast's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
12.5115.9319.35
Details
Intrinsic
Valuation
LowRealHigh
14.4720.7024.12
Details
Naive
Forecast
LowNextHigh
12.6916.1119.53
Details
3 Analysts
Consensus
LowTargetHigh
31.8535.0038.85
Details

Mesoblast February 6, 2026 Technical Indicators

Mesoblast Backtested Returns

As of now, Mesoblast Stock is not too volatile. Mesoblast has Sharpe Ratio of 0.044, which conveys that the firm had a 0.044 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Mesoblast, which you can use to evaluate the volatility of the firm. Please verify Mesoblast's Downside Deviation of 3.32, mean deviation of 2.65, and Risk Adjusted Performance of 0.0084 to check out if the risk estimate we provide is consistent with the expected return of 0.15%. Mesoblast has a performance score of 3 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 1.9, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Mesoblast will likely underperform. Mesoblast right now secures a risk of 3.41%. Please verify Mesoblast potential upside, as well as the relationship between the kurtosis and day typical price , to decide if Mesoblast will be following its current price movements.

Auto-correlation

    
  -0.51  

Good reverse predictability

Mesoblast has good reverse predictability. Overlapping area represents the amount of predictability between Mesoblast time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mesoblast price movement. The serial correlation of -0.51 indicates that about 51.0% of current Mesoblast price fluctuation can be explain by its past prices.
Correlation Coefficient-0.51
Spearman Rank Test-0.48
Residual Average0.0
Price Variance1.03
Mesoblast technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Mesoblast technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Mesoblast trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Mesoblast Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was fifty with a total number of output elements of eleven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Mesoblast volatility. High ATR values indicate high volatility, and low values indicate low volatility.

About Mesoblast Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Mesoblast on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Mesoblast based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Mesoblast price pattern first instead of the macroeconomic environment surrounding Mesoblast. By analyzing Mesoblast's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Mesoblast's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Mesoblast specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2023 2024 2026 (projected)
Days Sales Outstanding1.3K315.51344.69
PTB Ratio1.372.092.28

Mesoblast February 6, 2026 Technical Indicators

Most technical analysis of Mesoblast help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Mesoblast from various momentum indicators to cycle indicators. When you analyze Mesoblast charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Mesoblast February 6, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Mesoblast stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Mesoblast offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mesoblast's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mesoblast Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mesoblast Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mesoblast. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Mesoblast Stock, please use our How to Invest in Mesoblast guide.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Will Biotechnology sector continue expanding? Could Mesoblast diversify its offerings? Factors like these will boost the valuation of Mesoblast. Expected growth trajectory for Mesoblast significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Mesoblast data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.85)
Revenue Per Share
0.14
Quarterly Revenue Growth
4.586
Return On Assets
(0.05)
Return On Equity
(0.19)
Investors evaluate Mesoblast using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Mesoblast's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Mesoblast's market price to deviate significantly from intrinsic value.
Understanding that Mesoblast's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Mesoblast represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Mesoblast's market price signifies the transaction level at which participants voluntarily complete trades.